ID: ALA4093487

Max Phase: Preclinical

Molecular Formula: C40H44N8O7S

Molecular Weight: 780.91

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)c1nc2ccccc2s1

Standard InChI:  InChI=1S/C40H44N8O7S/c41-29(20-23-7-13-26(49)14-8-23)36(53)46-32(21-24-9-15-27(50)16-10-24)38(55)47-33(22-25-11-17-28(51)18-12-25)37(54)45-31(5-3-19-44-40(42)43)35(52)39-48-30-4-1-2-6-34(30)56-39/h1-2,4,6-18,29,31-33,49-51H,3,5,19-22,41H2,(H,45,54)(H,46,53)(H,47,55)(H4,42,43,44)/t29-,31-,32-,33-/m0/s1

Standard InChI Key:  HCTPBIOGHNIJMU-BBXFGWPUSA-N

Associated Targets(Human)

Transmembrane protease serine 6 209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matriptase 677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 780.91Molecular Weight (Monoisotopic): 780.3054AlogP: 2.37#Rotatable Bonds: 18
Polar Surface Area: 265.87Molecular Species: BASEHBA: 11HBD: 10
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.02CX Basic pKa: 11.59CX LogP: 2.48CX LogD: 0.88
Aromatic Rings: 5Heavy Atoms: 56QED Weighted: 0.03Np Likeness Score: -0.13

References

1. St-Georges C, Désilets A, Béliveau F, Ghinet M, Dion SP, Colombo É, Boudreault PL, Najmanovich RJ, Leduc R, Marsault É..  (2017)  Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids.,  129  [PMID:28219045] [10.1016/j.ejmech.2017.02.006]

Source